Position in ROIV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,462,500
+$750,000 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAMCO INC /NY/ holds $232,883,646 across 22 Biotechnology names. ROIV ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
138,648 | $101,247,702 | |
| 2 | ZLAB |
Zai Lab Ltd
|
1,658,318 | $31,192,961 | |
| 3 | TECH |
BIO-TECHNE Corp
|
561,441 | $29,340,906 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,072,189 | $25,260,772 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
1,273,341 | $10,224,928 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
125,486 | $4,083,314 | |
| 7 | MANE |
Veradermics, Inc
|
59,668 | $3,768,034 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
125,000 | $3,462,500 |
All Filings in ROIV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,462,500 | 125,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,712,500 | 125,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,588,650 | 105,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||